Global Human Single-Cell Multi-Omics Market Growth (Status and Outlook) 2021-2026
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Human Single-Cell Multi-Omics Market Size 2016-2026
- 2.1.2 Human Single-Cell Multi-Omics Market Size CAGR by Region 2020 VS 2021 VS 2026
- 2.2 Human Single-Cell Multi-Omics Segment by Type
- 2.2.1 Single-Cell Transcriptomics
- 2.2.2 Single-Cell Transcriptomics
- 2.2.3 Single-Cell Proteomics
- 2.3 Human Single-Cell Multi-Omics Market Size by Type
- 2.3.1 Global Human Single-Cell Multi-Omics Market Size CAGR by Type
- 2.3.2 Global Human Single-Cell Multi-Omics Market Size Market Share by Type (2016-2021)
- 2.4 Human Single-Cell Multi-Omics Segment by Application
- 2.4.1 Clinical Research
- 2.4.2 Translational Research
- 2.4.3 Synthetic Biology
- 2.5 Human Single-Cell Multi-Omics Market Size by Application
- 2.5.1 Global Human Single-Cell Multi-Omics Market Size CAGR by Application
- 2.5.2 Global Human Single-Cell Multi-Omics Market Size Market Share by Application (2016-2021)
3 Human Single-Cell Multi-Omics Market Size by Players
- 3.1 Human Single-Cell Multi-Omics Market Size Market Share by Players
- 3.1.1 Global Human Single-Cell Multi-Omics Revenue by Players (2019-2021E)
- 3.1.2 Global Human Single-Cell Multi-Omics Revenue Market Share by Players (2019-2021E)
- 3.2 Global Human Single-Cell Multi-Omics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Human Single-Cell Multi-Omics by Regions
- 4.1 Human Single-Cell Multi-Omics Market Size by Regions (2016-2021)
- 4.2 Americas Human Single-Cell Multi-Omics Market Size Growth (2016-2021)
- 4.3 APAC Human Single-Cell Multi-Omics Market Size Growth (2016-2021)
- 4.4 Europe Human Single-Cell Multi-Omics Market Size Growth (2016-2021)
- 4.5 Middle East & Africa Human Single-Cell Multi-Omics Market Size Growth (2016-2021)
5 Americas
- 5.1 Americas Human Single-Cell Multi-Omics Market Size by Country (2016-2021)
- 5.2 Americas Human Single-Cell Multi-Omics Market Size by Type (2016-2021)
- 5.3 Americas Human Single-Cell Multi-Omics Market Size by Application (2016-2021)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Human Single-Cell Multi-Omics Market Size by Region (2016-2021)
- 6.2 APAC Human Single-Cell Multi-Omics Market Size by Type (2016-2021)
- 6.3 APAC Human Single-Cell Multi-Omics Market Size by Application (2016-2021)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Human Single-Cell Multi-Omics by Country (2016-2021)
- 7.2 Europe Human Single-Cell Multi-Omics Market Size by Type (2016-2021)
- 7.3 Europe Human Single-Cell Multi-Omics Market Size by Application (2016-2021)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Human Single-Cell Multi-Omics by Region (2016-2021)
- 8.2 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Type (2016-2021)
- 8.3 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Application (2016-2021)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Human Single-Cell Multi-Omics Market Forecast
- 10.1 Global Human Single-Cell Multi-Omics Forecast by Regions (2021-2026)
- 10.1.1 Global Human Single-Cell Multi-Omics Forecast by Regions (2021-2026)
- 10.1.2 Americas Human Single-Cell Multi-Omics Forecast
- 10.1.3 APAC Human Single-Cell Multi-Omics Forecast
- 10.1.4 Europe Human Single-Cell Multi-Omics Forecast
- 10.1.5 Middle East & Africa Human Single-Cell Multi-Omics Forecast
- 10.2 Americas Human Single-Cell Multi-Omics Forecast by Countries (2021-2026)
- 10.2.1 United States Human Single-Cell Multi-Omics Market Forecast
- 10.2.2 Canada Human Single-Cell Multi-Omics Market Forecast
- 10.2.3 Mexico Human Single-Cell Multi-Omics Market Forecast
- 10.2.4 Brazil Human Single-Cell Multi-Omics Market Forecast
- 10.3 APAC Human Single-Cell Multi-Omics Forecast by Region (2021-2026)
- 10.3.1 China Human Single-Cell Multi-Omics Market Forecast
- 10.3.2 Japan Human Single-Cell Multi-Omics Market Forecast
- 10.3.3 Korea Human Single-Cell Multi-Omics Market Forecast
- 10.3.4 Southeast Asia Human Single-Cell Multi-Omics Market Forecast
- 10.3.5 India Human Single-Cell Multi-Omics Market Forecast
- 10.3.6 Australia Human Single-Cell Multi-Omics Market Forecast
- 10.4 Europe Human Single-Cell Multi-Omics Forecast by Country (2021-2026)
- 10.4.1 Germany Human Single-Cell Multi-Omics Market Forecast
- 10.4.2 France Human Single-Cell Multi-Omics Market Forecast
- 10.4.3 UK Human Single-Cell Multi-Omics Market Forecast
- 10.4.4 Italy Human Single-Cell Multi-Omics Market Forecast
- 10.4.5 Russia Human Single-Cell Multi-Omics Market Forecast
- 10.5 Middle East & Africa Human Single-Cell Multi-Omics Forecast by Region (2021-2026)
- 10.5.1 Egypt Human Single-Cell Multi-Omics Market Forecast
- 10.5.2 South Africa Human Single-Cell Multi-Omics Market Forecast
- 10.5.3 Israel Human Single-Cell Multi-Omics Market Forecast
- 10.5.4 Turkey Human Single-Cell Multi-Omics Market Forecast
- 10.5.5 GCC Countries Human Single-Cell Multi-Omics Market Forecast
- 10.6 Global Human Single-Cell Multi-Omics Forecast by Type (2021-2026)
- 10.7 Global Human Single-Cell Multi-Omics Forecast by Application (2021-2026)
11 Key Players Analysis
- 11.1 10x Genomics
- 11.1.1 10x Genomics Company Information
- 11.1.2 10x Genomics Human Single-Cell Multi-Omics Product Offered
- 11.1.3 10x Genomics Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.1.4 10x Genomics Main Business Overview
- 11.1.5 10x Genomics Latest Developments
- 11.2 1CellBio
- 11.2.1 1CellBio Company Information
- 11.2.2 1CellBio Human Single-Cell Multi-Omics Product Offered
- 11.2.3 1CellBio Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.2.4 1CellBio Main Business Overview
- 11.2.5 1CellBio Latest Developments
- 11.3 BGI Genomics
- 11.3.1 BGI Genomics Company Information
- 11.3.2 BGI Genomics Human Single-Cell Multi-Omics Product Offered
- 11.3.3 BGI Genomics Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.3.4 BGI Genomics Main Business Overview
- 11.3.5 BGI Genomics Latest Developments
- 11.4 Bio-Rad Laboratories
- 11.4.1 Bio-Rad Laboratories Company Information
- 11.4.2 Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Offered
- 11.4.3 Bio-Rad Laboratories Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.4.4 Bio-Rad Laboratories Main Business Overview
- 11.4.5 Bio-Rad Laboratories Latest Developments
- 11.5 Celsee
- 11.5.1 Celsee Company Information
- 11.5.2 Celsee Human Single-Cell Multi-Omics Product Offered
- 11.5.3 Celsee Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.5.4 Celsee Main Business Overview
- 11.5.5 Celsee Latest Developments
- 11.6 Fluidigm Corporation
- 11.6.1 Fluidigm Corporation Company Information
- 11.6.2 Fluidigm Corporation Human Single-Cell Multi-Omics Product Offered
- 11.6.3 Fluidigm Corporation Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.6.4 Fluidigm Corporation Main Business Overview
- 11.6.5 Fluidigm Corporation Latest Developments
- 11.7 Fluxion Biosciences
- 11.7.1 Fluxion Biosciences Company Information
- 11.7.2 Fluxion Biosciences Human Single-Cell Multi-Omics Product Offered
- 11.7.3 Fluxion Biosciences Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.7.4 Fluxion Biosciences Main Business Overview
- 11.7.5 Fluxion Biosciences Latest Developments
- 11.8 MissionBio
- 11.8.1 MissionBio Company Information
- 11.8.2 MissionBio Human Single-Cell Multi-Omics Product Offered
- 11.8.3 MissionBio Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.8.4 MissionBio Main Business Overview
- 11.8.5 MissionBio Latest Developments
- 11.9 NanoString Technologies
- 11.9.1 NanoString Technologies Company Information
- 11.9.2 NanoString Technologies Human Single-Cell Multi-Omics Product Offered
- 11.9.3 NanoString Technologies Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.9.4 NanoString Technologies Main Business Overview
- 11.9.5 NanoString Technologies Latest Developments
- 11.10 Takara Bio
- 11.10.1 Takara Bio Company Information
- 11.10.2 Takara Bio Human Single-Cell Multi-Omics Product Offered
- 11.10.3 Takara Bio Human Single-Cell Multi-Omics Revenue, Gross Margin and Market Share (2019-2021)
- 11.10.4 Takara Bio Main Business Overview
- 11.10.5 Takara Bio Latest Developments
12 Research Findings and Conclusion
According to this latest study, the 2021 growth of Human Single-Cell Multi-Omics will have significant change from previous year. By the most conservative estimates of global Human Single-Cell Multi-Omics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Human Single-Cell Multi-Omics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Single-Cell Multi-Omics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Single-Cell Transcriptomics
Single-Cell Genomics
Single-Cell Proteomics
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Clinical Research
Translational Research
Synthetic Biology
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio